Coopersurgical, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$21Mgeneral payments (2019-2025)
$28Kresearch payments (2019-2025)
23,234clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $3.1M
2020 $3.6M
2021 $3.4M
2022 $2.5M
2023 $4.3M
2024 $1.9M
2025 $1.6M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Gynecology $2.2M
Obstetrics & Gynecology $2.2M
Family Medicine $288K
Complex Family Planning $252K
Family $182K
Reproductive Endocrinology $155K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Arnold Advincula New York, NY Gynecology $1,360,135.29
Nathan Fischer Bloomfield, CT $568,279.62
David Turok Salt Lake City, UT Obstetrics & Gynecology $358,176.00
Mark Deutchman Denver, CO Family Medicine $256,375.53
Neena Qasba Farmington, CT Complex Family Planning $251,522.50
Marco Pelosi Bayonne, NJ Gynecology $163,482.29
Barry Sacks Natick, MA Diagnostic Radiology $148,769.11
Teresa Doss Wilmington, NC Family $136,280.00
Harry Reich Shavertown, PA Gynecology $135,621.49
Ethan Goldstein Bloomfield Hills, MI Obstetrics & Gynecology $133,985.84

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.